"Ancitabine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
| Descriptor ID |
D003504
|
| MeSH Number(s) |
D03.383.742.680.245.453.050 D13.570.065.300.050 D13.570.685.245.453.050
|
| Concept/Terms |
NSC-145,668- NSC-145,668
- NSC 145,668
- NSC145,668
- NSC-145668
- NSC 145668
- NSC145668
U-33,624A- U-33,624A
- U 33,624A
- U33,624A
- U-33624A
- U 33624A
- U33624A
|
Below are MeSH descriptors whose meaning is more general than "Ancitabine".
Below are MeSH descriptors whose meaning is more specific than "Ancitabine".
This graph shows the total number of publications written about "Ancitabine" by people in this website by year, and whether "Ancitabine" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Ancitabine" by people in Profiles.
-
Aqueous conversion kinetics and mechanisms of ancitabine, a prodrug of the antileukemic agent cytarabine. J Pharm Sci. 1984 Jul; 73(7):896-902.
-
Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine. J Pharm Sci. 1984 Jun; 73(6):728-32.
-
Drug stability in liposomal suspensions: hydrolysis of indomethacin, cyclocytidine, and p-nitrophenyl acetate. J Pharm Sci. 1982 Dec; 71(12):1394-8.